These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6160617)

  • 21. [Structure and function of clotting factor VIII: the results of fundamental research].
    Beck EA; Furlan M
    Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
    [No Abstract]   [Full Text] [Related]  

  • 22. Puerperal acquired factor VIII inhibitor causing a von Willebrand-like syndrome in a patient with anti-DNA antibodies.
    Jackson N; Hashim ZA; Zainal NA; Jamaluddin N
    Singapore Med J; 1995 Apr; 36(2):230-1. PubMed ID: 7676276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet function and diabetes mellitus.
    Colwell JA; Halushka PV; Sarji KE; Sagel J
    Med Clin North Am; 1978 Jul; 62(4):753-66. PubMed ID: 355740
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function.
    Ruan C; Tobelem G; McMichael AJ; Drouet L; Legrand Y; Degos L; Kieffer N; Lee H; Caen JP
    Br J Haematol; 1981 Dec; 49(4):511-9. PubMed ID: 6797459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acquired von Willebranol syndrome--its pathophysiology, diagnosis and treatment].
    Mohri H
    Rinsho Ketsueki; 2001 Jul; 42(7):525-36. PubMed ID: 11524842
    [No Abstract]   [Full Text] [Related]  

  • 26. Factor VIII physiology and pathology in man.
    Koutts J; Howard MA; Firkin BG
    Prog Hematol; 1979; 11():115-45. PubMed ID: 392590
    [No Abstract]   [Full Text] [Related]  

  • 27. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular defects in interactions of platelets with the vessel wall.
    George JN; Nurden AT; Phillips DR
    N Engl J Med; 1984 Oct; 311(17):1084-98. PubMed ID: 6384783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.
    Mohri H
    J Thromb Thrombolysis; 2003 Jun; 15(3):141-9. PubMed ID: 14739623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanism of platelet adhesion.
    Hardisty RM
    Adv Exp Med Biol; 1985; 192():411-8. PubMed ID: 2422888
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)].
    Tobelem G; Drouet L; Caen J
    Nouv Presse Med; 1980 Mar; 9(13):949-54. PubMed ID: 6987618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay.
    Brinkhous KM; Read MS; Reddick RL; Griggs TR
    Ann N Y Acad Sci; 1981; 370():191-204. PubMed ID: 7023318
    [No Abstract]   [Full Text] [Related]  

  • 35. Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus.
    Viallard JF; Pellegrin JL; Vergnes C; Borel-Derlon A; Clofent-Sanchez G; Nurden AT; Leng B; Nurden P
    Br J Haematol; 1999 May; 105(2):532-7. PubMed ID: 10233433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing basic and clinical research on von Willebrand factor and von Willebrand disease.
    Ruggeri ZM
    Thromb Haemost; 2000 Aug; 84(2):147-9. PubMed ID: 10959682
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction between platelets and von Willebrand factor provides a new scheme for primary haemostasis.
    Caen JP; Levy-Toledano S
    Nat New Biol; 1973 Aug; 244(135):159-60. PubMed ID: 4541893
    [No Abstract]   [Full Text] [Related]  

  • 38. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract]   [Full Text] [Related]  

  • 39. Von Willebrand disease.
    Schneppenheim R
    Eur J Pediatr; 1996 Sep; 155(9):751-2. PubMed ID: 8874104
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor.
    Shenkman B; Linder N; Savion N; Tamarin I; Dardik R; Kennet G; German B; Varon D
    Pediatr Res; 1999 Feb; 45(2):270-5. PubMed ID: 10022601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.